Department of Oral and Maxillofacial Surgery, MKA Kennemer & Meer, Haarlem, the Netherlands; Department of Oral and Maxillofacial Surgery, Amphia Hospital, Breda, the Netherlands.
Department of Oral and Maxillofacial Surgery, BovenIJ Hospital, Amsterdam, the Netherlands.
Int J Oral Maxillofac Surg. 2021 Dec;50(12):1632-1637. doi: 10.1016/j.ijom.2021.04.010. Epub 2021 May 11.
The treatment of young patients with missing teeth and an atrophied alveolar process after trauma or agenesis of a tooth can be challenging. The aim of this study was to evaluate autotransplantation of a premolar after pre-autotransplantation alveolar process augmentation (PAPA) as a treatment option for these patients. A retrospective cohort study was implemented to analyse the PAPA procedure and subsequent autotransplantation procedure. Alveolar process augmentation was performed using different types of autologous bone grafts. Subsequent autotransplantation of one or more premolars was performed approximately 4 months later. Nine patients with a mean age of 12 years were included. Twelve premolars were transplanted after a PAPA procedure: seven in the maxillary incisor region, four in the mandibular premolar region, and one in the mandibular incisor region. Initially all transplanted teeth functioned well. However, one mandibular premolar that was transplanted in the maxillary incisor region was lost because of resorption after 6 years of follow-up. The other 11 transplanted teeth functioned well. The mean follow-up was 6 years (range 3-13 years). The results showed that autotransplantation can be facilitated by PAPA with a high chance of success. It can therefore be a valuable addition to other existing treatment options.
对于因外伤或牙齿缺失而导致缺牙和牙槽骨萎缩的年轻患者的治疗具有一定挑战性。本研究旨在评估预自体移植牙槽骨增量(PAPA)后自体移植前磨牙作为这些患者的治疗选择。采用回顾性队列研究分析 PAPA 程序和随后的自体移植程序。使用不同类型的自体骨移植物进行牙槽骨增量。大约 4 个月后,进行了一颗或多颗前磨牙的后续自体移植。共纳入 9 名年龄平均为 12 岁的患者。在 PAPA 手术后共移植了 12 颗前磨牙:上颌切牙区 7 颗,下颌前磨牙区 4 颗,下颌切牙区 1 颗。最初所有移植的牙齿功能良好。然而,1 颗在上颌切牙区移植的下颌前磨牙在随访 6 年后因吸收而丢失。其他 11 颗移植牙功能良好。平均随访时间为 6 年(3-13 年)。结果表明,PAPA 有助于自体移植,成功率较高。因此,它可以成为其他现有治疗选择的有价值的补充。